Endothelial progenitor cell capture stents: will this technology find its niche in contemporary practice?

Late Stent Thrombosis After Drug-Eluting Stent

(2009) William Wijns   CIRCULATION

Genous™ endothelial progenitor cell capturing stent vs. the Taxus Liberté stent in patients with de novo coronary lesions with a high-risk of coronary restenosis: a randomized, single-centre, pilot study

(2009) Marcel A.M. Beijk et al.   EUROPEAN HEART JOURNAL

1-Year Results of the Hydroxyapatite Polymer-Free Sirolimus-Eluting Stent for the Treatment of Single De Novo Coronary Lesions

(2009) J. Ribamar Costa et al.   JACC-Cardiovascular Interventions

Durability of Antirestenotic Efficacy in Drug-Eluting Stents With and Without Permanent Polymer

(2009) Robert A. Byrne et al.   JACC-Cardiovascular Interventions

Cell therapies for therapeutic angiogenesis: back to the bench

(2009) Daniel P Sieveking et al.   VASCULAR MEDICINE

Percutaneous coronary intervention utilizing a new endothelial progenitor cells antibody-coated stent: A prospective single-center registry in high-risk patients

(2008) Marco Miglionico et al.   CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS

Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trial

(2008) Stephan Windecker et al.   LANCET

A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trial

(2008) John A Ormiston et al.   LANCET